1020719-39-4
1020719-39-4
Chemical Structure
Licarbazepine-d4
Synonym(s): BIA 2-005-d4;GP 47779-d4
- CAS No.: 1020719-39-4
- Formula:C15H10D4N2O2
- Molecular Weight:258.31
IUPAC Name: 10-hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-1,2,3,4-d4-5-carboxamide
InChIKey: BMPDWHIDQYTSHX-DNZPNURCSA-N
SMILES: NC(N1C2=CC=CC=C2C(CC3=C([2H])C([2H])=C([2H])C([2H])=C31)O)=O
Biological Activity: Licarbazepine-d4 is the deuterium labeled Licarbazepine (HY-108506). Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Licarbazepine-d4 | Licarbazepine-d4 is the deuterium labeled Licarbazepine (HY-108506). Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Licarbazepine (Standard) | 99.90% | Licarbazepine (Standard) is the analytical standard of Licarbazepine. This product is intended for research and analytical applications. Licarbazepine (BIA 2-005; GP 47779) is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Licarbazepine-d8 | Licarbazepine-d8 (BIA 2-005-d8) is deuterium labeled Licarbazepine. Licarbazepine (BIA 2-005; GP 47779)?is a?voltage-gated sodium channel?blocker?with?anticonvulsant?and?mood-stabilizing?effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Licarbazepine-d3 | Licarbazepine-d3 is the deuterium labeled Licarbazepine (HY-108506). Licarbazepine is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Licarbazepine-d4-1 | 99.28% | Licarbazepine-d4-1 is deuterium labeled Licarbazepine. Licarbazepine (BIA 2-005; GP 47779)?is a?voltage-gated sodium channel?blocker?with?anticonvulsant?and?mood-stabilizing?effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Licarbazepine | 99.82% | Licarbazepine (BIA 2-005; GP 47779) is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Eslicarbazepine | 99.94% | Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R)-Eslicarbazepine acetate | (R)-Eslicarbazepine acetate (BIA 2-059) is the R-enantiomer of Eslicarbazepine acetate (HY-B0703). Eslicarbazepine acetate is an antiepileptic agent, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
10,11-Dihydroxycarbamazepine (mixture of diastereomers) | 99.05% | 10,11-Dihydroxycarbamazepine (mixture of diastereomers) is a metabolite of the anticonvulsant Carbamazepine (HY-B0246). Carbamazepine is an orally active pressure-sensitive sodium ion channel blocker. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oxcarbazepine (Standard) | 99.88% | Oxcarbazepine (Standard) is the analytical standard of Oxcarbazepine. This product is intended for research and analytical applications. Oxcarbazepine is a sodium channel blocker. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines. Anti-cancer and anticonvulsant effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Eslicarbazepine acetate (Standard) | ≥98% | Eslicarbazepine acetate (Standard) is the analytical standard of Eslicarbazepine acetate. This product is intended for research and analytical applications. Eslicarbazepine acetate (BIA 2-093), an antiepileptic agent, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
10,11-Dihydrocarbamazepine | 98.81% | 10,11-Dihydrocarbamazepine is the active metabolite of Oxcarbazepine. 10,11-Dihydrocarbamazepine also is an intermediate. Oxcarbazepine is rapidly and almost completely converted to 10,11-Dihydrocarbamazepine with probable Anticonvulsant efficacy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbamazepine 10,11-epoxide | 99.21% | Carbamazepine 10,11-epoxide is a metabolite of Carbamazepine (HY-B0246). Carbamazepine 10,11-epoxide can be used to monitor for Carbamazepine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbamazepine 10,11-epoxide-13C,15N | Carbamazepine 10,11-epoxide-13C,15N is the 13C and 15N labeled Carbamazepine 10,11-epoxide (HY-W013378). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbamazepine 10,11-epoxide-13C | Carbamazepine 10,11-epoxide-13C is the 13C labeled Carbamazepine 10,11-epoxide (HY-W013378). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Carbamazepine 10,11-epoxide-13C-1 | Carbamazepine 10,11-epoxide-13C-1 is the 13C labeled Carbamazepine 10,11-epoxide (HY-W013378). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
